nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A fine addition: Finerenone in the evolving landscape of heart failure with preserved ejection fraction
|
Halaseh, Rami |
|
|
30 |
2 |
p. 287-291 |
artikel |
2 |
Clinical and research applications of natural language processing for heart failure
|
Girouard, Michael P. |
|
|
30 |
2 |
p. 407-415 |
artikel |
3 |
Conduction system pacing in heart failure: Time for a paradigm shift?
|
Vlachakis, Panayotis K. |
|
|
30 |
2 |
p. 365-380 |
artikel |
4 |
Could SGLT2 inhibitors improve outcomes in patients with heart failure and significant valvular heart disease? Need for action
|
Kamperidis, Vasileios |
|
|
30 |
2 |
p. 353-356 |
artikel |
5 |
Diagnosis and management of hypertrophic cardiomyopathy: European vs. American guidelines
|
Aimo, Alberto |
|
|
30 |
2 |
p. 315-325 |
artikel |
6 |
Diuretic strategies in acute decompensated heart failure
|
Lo, Kevin Bryan |
|
|
30 |
2 |
p. 417-430 |
artikel |
7 |
Hyperkalemia management: a multidisciplinary expert panel’s perspective on the role of new potassium binders
|
Fonseca, Cândida |
|
|
30 |
2 |
p. 271-286 |
artikel |
8 |
Machine learning in predicting heart failure survival: a review of current models and future prospects
|
Kokori, Emmanuel |
|
|
30 |
2 |
p. 431-442 |
artikel |
9 |
Maternal heart failure: state-of-the-art review
|
Najam, Usman S. |
|
|
30 |
2 |
p. 337-351 |
artikel |
10 |
Peripartum cardiomyopathy in the twenty-first century: a review of the pathophysiology and clinical trials for novel disease-specific therapeutics
|
Callender, Kristen |
|
|
30 |
2 |
p. 443-451 |
artikel |
11 |
Perspectives on why DanGer Shock is the first positive trial on mechanical circulatory support in cardiogenic shock
|
Mondellini, Giulio M. |
|
|
30 |
2 |
p. 381-385 |
artikel |
12 |
Potential effects of beta-blockers in HFpEF
|
Tokarczyk, Wojciech |
|
|
30 |
2 |
p. 357-364 |
artikel |
13 |
Sacubitril/valsartan in a wide spectrum of heart failure patients (from mechanisms of action to outcomes in specific populations)
|
Rajzer, Przemyslaw |
|
|
30 |
2 |
p. 387-405 |
artikel |
14 |
Sodium-glucose co-transporter 2 inhibitors in left ventricular assist device and heart transplant recipients: a mini-review
|
Alyaydin, Emyal |
|
|
30 |
2 |
p. 327-335 |
artikel |
15 |
The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review
|
Othman, Leen |
|
|
30 |
2 |
p. 453-467 |
artikel |
16 |
The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined
|
Jiang, Haoran |
|
|
30 |
2 |
p. 293-314 |
artikel |